¸Þµð¾÷

´ëÇк´¿ø Çѹ溴¿ø
Á¾ÇÕº´¿ø ³ëÀκ´¿ø
°Ô½ÃÆÇ
°Ç°­Á¤º¸
º´¿ø¾à±¹Á¤º¸
Èú¸µ½ºÅ丮
Áúº´Á¤º¸
ÀǾàÇ°Á¤º¸
ÀÇÇм­Àû
ÀÓ´ëºÐ¾ç¸Å¸Å
¿¬¼ö°­ÁÂ
±³À°Á¤º¸
¸ÞµðÅå
´ëÇк´¿ø Á¾ÇÕº´¿ø Çѹ溴¿ø Ä¡°úº´¿ø ÇÑÀÇ¿ø ³ëÀÎÀü¹®º´¿ø º¸°Ç¼Ò
¼­¿ï ºÎ»ê ÀÎõ ´ë±¸ ´ëÀü ±¤ÁÖ ¿ï»ê °æ±â °­¿ø ÃæºÏ Ãæ³² °æºÏ °æ³² ÀüºÏ Àü³² Á¦ÁÖ ¼¼Á¾
Ä¡°ú ¾È°ú ÇǺΰú ¼ºÇü¿Ü°ú »êºÎÀΰú ºñ´¢±â°ú ¿Ü°ú ³»°ú Á¤Çü¿Ü°ú À̺ñÀÎÈÄ°ú ¼Ò¾Æ°ú ¾à±¹

¸ñ·Ï ¼öÁ¤ »èÁ¦

´ëÇѽÉÇ÷°üÁßÀçÇÐȸ Á¦19ȸ µ¿°è±¹Á¦Çмú´ëȸ(1ÀÏÂ÷) : 2023-01-13

ÃßõÇϱâ
¿¬¼ö°­Á À̹øÁÖ BEST
 
´ëÇѽÉÇ÷°üÁßÀçÇÐȸ Á¦19ȸ µ¿°è±¹Á¦Çмú´ëȸ(1ÀÏÂ÷) : 2023-01-13
±³À°ÀÏÀÚ : 2023-01-13
±³À°Àå¼Ò : ¼­¿ï½Å¶óÈ£ÅÚ ´ÙÀ̳ʽºÆ¼ ¿Ü 2°³·ë  
±³À°ÁÖÁ¦ : ´ëÇѽÉÇ÷°üÁßÀçÇÐȸ Á¦19ȸ µ¿°è±¹Á¦Çмú´ëȸ(1ÀÏÂ÷) 
ÁÖÃÖ±â°ü : ´ëÇѽÉÇ÷°üÁßÀçÇÐȸ
´ã´çÀÚ : Á¶¿¹¸®
¿¬¶ôó : 02-582-8222  
À̸ÞÀÏ : yehc@kscvi.org      
±³À°Á¾·ù : ³»°ú      
Âü¼®¿¹»óÀοø : 800¸í
Èñ¸ÁÆòÁ¡ : 6Á¡  
Áö¿ª : ¼­¿ïƯº°½Ã
±³À°½Ã°£ : 20 ½Ã°£ 52ºÐ  
¼¼ºÎ¼ö°­·á : 120,000¿ø      
ºñ°í - Àü¹®ÀÇ,°³¿øÀÇ,ÀϹÝÀÇ:(ÇöÀåµî·Ï)60,000¿ø - ÀüÀÓÀÇ,Àü°øÀÇ,°£È£»ç,ÀÇ·á±â»ç,ÀÇ´ë»ý,±ºÀÇ°ü,°øÁߺ¸°ÇÀÇ,ÀÓ»óº´¸®»ç,Àǹ«±â·Ï»ç:(ÇöÀåµî·Ï)50,000¿ø - »ê¾÷ü,±âŸ:(ÇöÀåµî·Ï)120,000¿ø - ÇÐȸ Á¤È¸¿ø(Àü³âµµ ȸºñ¿Ï³³ÀÚ): ¹«·á      

±¸ºÐ ¿ùÀÏ °­ÀǽǠ½Ã°£ ±³À°Á¦¸ñ  °­»ç¸í(¼Ò¼Ó) Çʼö°ú¸ñ
±³À°½Ã°£ 01-13 Main Arena 09:00~09:10 TAVR(Transcatheter Aortic Valve Replacement) valve-in-valve: TAVR(Transcatheter Aortic Valve Replacement) in SAVR(Surgical Aortic Valve Replacement) and TAVR(Transcatheter Aortic Valve Replacement) in TAVR(Transcatheter Aortic Valve Replacement)  ÇÑÁ¤±Ô(¼­¿ïÀÇ´ë) 
±³À°½Ã°£ 01-13 Main Arena 09:10~09:20 SCAI(The Society for Cardiovascular Angiography and Interventions)  Molly Szerlip(Baylor Scott & White The Heart Hospital Plano. USA) 
±³À°½Ã°£ 01-13 Main Arena 09:20~09:30 TEER(Transcatheter Edge to Edge Repair) in commisural MR(Mitral Regurgitation)  °­µµÀ±(¿ï»êÀÇ´ë) 
±³À°½Ã°£ 01-13 Main Arena 09:30~09:40 SCAI(The Society for Cardiovascular Angiography and Interventions)  Anita Asgar(Montreal Heart Institute. Canada) 
Åä·Ð 01-13 Main Arena 09:40~10:00 Discussion  () 
±³À°½Ã°£ 01-13 Symposium Arena 09:00~09:10 Recent Advances in CABG(Coronary Artery Bypass Grafting)  È²È£¿µ(¼­¿ïÀÇ´ë) 
±³À°½Ã°£ 01-13 Symposium Arena 09:10~09:20 PCI(Percutaneous Coronary Intervention) vs. CABG(Coronary Artery Bypass Grafting) for LM(Left Main) and Multivessel Disease  ¹Ú½ÂÁ¤(¿ï»êÀÇ´ë) 
±³À°½Ã°£ 01-13 Symposium Arena 09:20~09:30 PCI(Percutaneous Coronary Intervention) vs. CABG(Coronary Artery Bypass Grafting) for iCMP(Ischemic Cardiomyopathy)  ±èÈ¿¼ö(¼­¿ïÀÇ´ë) 
±³À°½Ã°£ 01-13 Symposium Arena 09:30~09:40 How to Optimize Revascularization Results in Complex CAD(Coronary Artery Disease)  ±èº´±Ø(¿¬¼¼ÀÇ´ë) 
Åä·Ð 01-13 Symposium Arena 09:40~10:00 Discussion  () 
±³À°½Ã°£ 01-13 Presentation Arena 09:00~09:10 Choice of Vascular Access for Cardiovascular Intervention  À¯»ó¿ë(¿ï»êÀÇ´ë) 
±³À°½Ã°£ 01-13 Presentation Arena 09:10~09:20 Step by Step Instruction for Distal Radial Artery  ÀÌÁØ¿ø(¿¬¼¼¿øÁÖÀÇ´ë) 
±³À°½Ã°£ 01-13 Presentation Arena 09:20~09:30 What We Need to Know to Prevent Complications in TRI(Trans-radial Intervention)  ±èµ¿±â(ÀÎÁ¦ÀÇ´ë) 
±³À°½Ã°£ 01-13 Presentation Arena 09:30~09:40 Use of Femoral Closure Devices to avoid Vascular Complications  ±Ç¿À¼º(°¡Å縯ÀÇ´ë) 
Åä·Ð 01-13 Presentation Arena 09:40~10:00 Discussion  () 
È޽Ġ01-13  10:00~10:05 Break  () 
±³À°½Ã°£ 01-13 Main Arena 10:05~10:20 For Fellows-in-Training Aiming for a Career in Academic Cardiology  Deepak Bhatt(Brigham and Women) 
Åä·Ð 01-13 Main Arena 10:20~10:35 Real-time Interview & Q/A  ±¸º»±Ç(¼­¿ïÀÇ´ë) 
±³À°½Ã°£ 01-13 Main Arena 10:35~10:50 For Early Interventional Cardiologist: How to Be a Master? A to Z  Emmanouil Brilakis(Allina Health Minneapolis Heart Institute. USA) 
Åä·Ð 01-13 Main Arena 10:50~11:05 Real-time Interview & Q/A  Àü±¹Áø(ºÎ»êÀÇ´ë) 
±³À°½Ã°£ 01-13 Symposium Arena 10:05~10:15 Scenario 1. Severe Stenosis in Coronary CT(Computed Tomography) in Asymptomatic Patient  ¼­Á¤¿ø(¼­¿ïÀÇ´ë) 
±³À°½Ã°£ 01-13 Symposium Arena 10:15~10:25 Scenario 2. Asymptomatic Large Ischemic Burden During FU(Follow Up) after PCI(Percutaneous Coronary Intervention)/CABG(Coronary Artery Bypass Grafting)  À±ÇõÁØ(°è¸íÀÇ´ë) 
±³À°½Ã°£ 01-13 Symposium Arena 10:25~10:35 Scenario 3. Tight Coronary Stenosis Before Undelayable Surgery  È²¼®Àç(°æ»óÀÇ´ë) 
Åä·Ð 01-13 Symposium Arena 10:35~11:05 Discussion  () 
±³À°½Ã°£ 01-13 Presentation Arena 10:05~10:20 Vascular Access Complications  Á¶À±Çü(¸íÁöº´¿ø) 
±³À°½Ã°£ 01-13 Presentation Arena 10:20~10:35 Coronary Perforation  ½Å»óÈÆ(ÀÌÈ­ÀÇ´ë) 
±³À°½Ã°£ 01-13 Presentation Arena 10:35~10:50 Balloon Fracture & Coronary Implant Loss  ±è»ó¹Î(ÃæºÏÀÇ´ë) 
±³À°½Ã°£ 01-13 Presentation Arena 10:50~11:05 Guidewire Loss  ¹Ú»óÈ£(¼øõÇâÀÇ´ë) 
È޽Ġ01-13  11:05~11:10 Break  () 
±³À°½Ã°£ 01-13 Main Arena 11:10~11:40 CAD(Coronary Artery Disease): Expert A-to-Z Tips and Techniques - Case 1: Left Main Bifurcation - Crush Technique  Ã¤ÀÎÈ£(¼­¿ïÀÇ´ë) 
±³À°½Ã°£ 01-13 Main Arena 11:40~12:10 CAD(Coronary Artery Disease): Expert A-to-Z Tips and Techniques - Case 2: Simple Case with IVUS(Intravascular Ultrasonography) and FFR(Fractional Flow Reserve) Guidance  ¿¬ÅÂÁø(¼­¿ïÀÇ´ë) 
±³À°½Ã°£ 01-13 Symposium Arena 11:10~11:20 Moderate Aortic Stenosis, Moderate Risk Patients: Expanding TAVR(Transcatheter Aortic Valve Replacement)  °­ÁöÈÆ(¼­¿ïÀÇ´ë) 
±³À°½Ã°£ 01-13 Symposium Arena 11:20~11:30 Cerebral Protection Devices (CPD): Are You Ready?  ¹Ú´ö¿ì(¿ï»êÀÇ´ë) 
±³À°½Ã°£ 01-13 Symposium Arena 11:30~11:40 Valve-in-Valve, TAV(Transcatheter Aortic Valve)-in-Valve: Feasibility, Durability and Repeatability  È²º´Èñ(°¡Å縯ÀÇ´ë) 
±³À°½Ã°£ 01-13 Symposium Arena 11:40~11:50 TAVR(Transcatheter Aortic Valve Replacement) in KOREA 2023, Before and After Reimbursement  Â÷Á¤ÁØ(°í·ÁÀÇ´ë) 
Åä·Ð 01-13 Symposium Arena 11:50~12:10 Discussion  () 
±³À°½Ã°£ 01-13 Presentation Arena 11:10~11:25 Atrial Fibrillation Patients Underwent CHIP PCI(High Risk Percutaneous Coronary Intervention) with High HASBLED Score(Bleeding Risk Score)  ¹èÀåȯ(ÃæºÏÀÇ´ë) 
±³À°½Ã°£ 01-13 Presentation Arena 11:25~11:40 Stabilized ACS(Acute Coronary Syndrome) Patients with History of Recurrent Ischemic Events and Bleeding  ¹Ú¿ëÈÖ(°æ»óÀÇ´ë) 
±³À°½Ã°£ 01-13 Presentation Arena 11:40~11:55 Cardiogenic Shock Patients after PCI(Percutaneous Coronary Intervention) with/without ECMO(Extracorporeal membrane oxygenation)  ¾È¼º±Õ(¿¬¼¼¿øÁÖÀÇ´ë) 
Åä·Ð 01-13 Presentation Arena 11:55~12:10 Discussion  () 
È޽Ġ01-13  12:10~12:15 Break  () 
½Ä»ç 01-13 Main Arena 12:15~13:15 Luncheon Symposium 1 - Amgen  () 
½Ä»ç 01-13 Symposium Arena 12:15~13:15 LunLuncheon Symposium 2 - Novartis  () 
½Ä»ç 01-13 Presentation Arena 12:15~13:15 Luncheon Symposium 3 - Servier  () 
±âŸ 01-13 E-poster Zone & Learning Center 13:15~14:00 Coffee Break & Moderated Abstract E-poster Presentation  () 
±³À°½Ã°£ 01-13 Main Arena 14:00~14:10 ¿©¼º½ÉÇ÷°üÁßÀç½Ã¼úÀÇ»ç: ½ÉÇ÷°üÁßÀçºÐ¾ß¿¡ ¿©ÀÇ»çÀÇ Âü¿©¸¦ ´Ã¸®·Á¸é ¾î¶»°Ô ÇØ¾ß Çұ¼­Á¤¿ø(¼­¿ïÀÇ´ë) 
±³À°½Ã°£ 01-13 Main Arena 14:10~14:20 È¯ÀÚ Àü¿ø: ¹®Á¦Á¡µé°ú ÁÖÀÇ »çÇ׵頠¹Úâ¹ü(°æÈñÀÇ´ë) 
±³À°½Ã°£ 01-13 Main Arena 14:20~14:30 ÇʼöÀÇ·á ³í¶õ: ºÒ¸íÈ®ÇÑ Á¤ÀÇ¿Í ¾Ö¸ÅÇÑ ´ëÃ¥ - ½ÉÇ÷°üÁßÀçÀÇ»ç´Â?  ±èÃæ±â(ÀÌÈ­ÀÇ´ë) 
±³À°½Ã°£ 01-13 Main Arena 14:30~14:40 ¹æ»ç¼± ¾ÈÀüÀ» À§ÇÑ ³ë·Â  ¹Ú»ó¹Î(À»ÁöÀÇ´ë) 
Åä·Ð 01-13 Main Arena 14:40~15:00 Discussion  () 
±³À°½Ã°£ 01-13 Symposium Arena 14:00~15:00 PAD(Peripheral Artery Disease): Expert A-to-Z Tips and Techniques - Case: PTA-SFA(Percutaneous Transluminal Angioplasty-Superficial Femoral Artery) Case  ÀÌÀçȯ(Ãæ³²ÀÇ´ë) 
±³À°½Ã°£ 01-13 Presentation Arena 14:00~14:10 Tips for Making a Strategy with Imaging Tools  È«¿µÁØ(Àü³²ÀÇ´ë) 
±³À°½Ã°£ 01-13 Presentation Arena 14:10~14:20 Tips for Making a Strategy with Physiology Tools  ±¸º»±Ç(¼­¿ïÀÇ´ë) 
±³À°½Ã°£ 01-13 Presentation Arena 14:20~14:30 Tips for Good Kissing and POT(Proximal Optimisation Technique) Technique  À±¿µÁø(¿¬¼¼¿øÁÖÀÇ´ë) 
±³À°½Ã°£ 01-13 Presentation Arena 14:30~14:40 Tips for Prevent a Disastrous Procedure  ÃßÀºÈ£(°¡Å縯ÀÇ´ë) 
Åä·Ð 01-13 Presentation Arena 14:40~15:00 Discussion  () 
È޽Ġ01-13  15:00~15:05 Break  () 
±³À°½Ã°£ 01-13 Main Arena 15:05~16:05 SHD(Structural Heart Disease): Expert A-to-Z Tips and Techniques - Case: TAVI(Transcatheter Aortic Valve Implantation)  °í¿µ±¹(¿¬¼¼ÀÇ´ë) 
±³À°½Ã°£ 01-13 Symposium Arena 15:05~15:15 Multidisciplinary Team Approach for CLI(Critical limb ischemia)  ±è¿õ(¿µ³²ÀÇ´ë) 
±³À°½Ã°£ 01-13 Symposium Arena 15:15~15:25 Applying Tissue Perfusion Image for CLI(Critical limb ischemia) Intervention  À̽ÂÁØ(¿¬¼¼ÀÇ´ë) 
±³À°½Ã°£ 01-13 Symposium Arena 15:25~15:35 How to Overcome Heavily Calcified Lesion during CLI(Critical limb ischemia) Intervention  ±èÁö¹Ú(°í·ÁÀÇ´ë) 
±³À°½Ã°£ 01-13 Symposium Arena 15:35~15:45 Surgical Revascularization for CLI(Critical limb ischemia)  À±¿ì¼º(°æºÏÀÇ´ë) 
Åä·Ð 01-13 Symposium Arena 15:45~16:05 Discussion  () 
±³À°½Ã°£ 01-13 Presentation Arena 15:05~15:15 How I Evaluate De Novo Lesion using IVUS(Intravascular Ultrasonography)  ÀÓ¿µÈ¿(ÇѾçÀÇ´ë) 
±³À°½Ã°£ 01-13 Presentation Arena 15:15~15:25 How I Evaluate De Novo Lesion using OCT(Optical Coherence Tomography)  ÇãÁ¤È£(°í½ÅÀÇ´ë) 
Åä·Ð 01-13 Presentation Arena 15:25~15:35 Discussion  () 
±³À°½Ã°£ 01-13 Presentation Arena 15:35~15:45 How I Use IVUS(Intravascular Ultrasonography) in CTO(Chronic Total Occlusion) Lesion  ÀÌÁßÈñ(¿¬¼¼¿øÁÖÀÇ´ë) 
±³À°½Ã°£ 01-13 Presentation Arena 15:45~15:55 How I Use OCT(Optical Coherence Tomography) in Calcified Lesion  À±ÇõÁØ(°è¸íÀÇ´ë) 
Åä·Ð 01-13 Presentation Arena 15:55~16:05 Discussion  () 
È޽Ġ01-13  16:05~16:10 Break  () 
±³À°½Ã°£ 01-13 Main Arena 16:10~16:20 My PCI(Percutaneous Coronary Intervention) Approach to Patients with Spontaneous Coronary Artery Dissection  ±èÇö±¹(Á¶¼±ÀÇ´ë) 
±³À°½Ã°£ 01-13 Main Arena 16:20~16:30 My PCI(Percutaneous Coronary Intervention) Approach to Patients with Non-culprit Lesion in STEMI(ST-elevation Myocardial Infarction): FFR(Fractional Flow Reserve) or Not  ÀÌÁÖ¸í(¼º±Õ°üÀÇ´ë) 
±³À°½Ã°£ 01-13 Main Arena 16:30~16:40 My PCI(Percutaneous Coronary Intervention) Approach to Patients with Multivessel Disease and Cardiogenic Shock: Complete Revascularization or Not  ±è¹Îö(Àü³²ÀÇ´ë) 
±³À°½Ã°£ 01-13 Main Arena 16:40~16:50 My PCI(Percutaneous Coronary Intervention) Approach to Patients with Severe LV(Left Ventricular) Dysfunction Following AMI(Acute Myocardial Infarction): Viability Test or Not  ÀÌÀåÈÆ(°æºÏÀÇ´ë) 
Åä·Ð 01-13 Main Arena 16:50~17:10 Discussion  () 
±³À°½Ã°£ 01-13 Symposium Arena 16:10~16:20 How to Do Pre-procedure Planning for Successful EVAR(Endovascular Aneurysm Repair)  ±è»ó¹Î(ÃæºÏÀÇ´ë) 
±³À°½Ã°£ 01-13 Symposium Arena 16:20~16:30 How to Overcome Unfavorable Anatomy for Successful EVAR(Endovascular Aneurysm Repair)  À̱¤ÈÆ(¿¬¼¼ÀÇ´ë) 
±³À°½Ã°£ 01-13 Symposium Arena 16:30~16:40 How to Overcome Complications during EVAR(Endovascular Aneurysm Repair)  ±èÁÖÇÑ(Àü³²ÀÇ´ë) 
±³À°½Ã°£ 01-13 Symposium Arena 16:40~16:50 How to Manage of Endoleak (Andoanchor, Onyx, Type II etc)  ±ÇÁØÈ£(¿¬¼¼ÀÇ´ë) 
Åä·Ð 01-13 Symposium Arena 16:50~17:10 Discussion  () 
±³À°½Ã°£ 01-13 Presentation Arena 16:10~16:20 Parallel Wire Technique  ½Å»óÈÆ(ÀÌÈ­ÀÇ´ë) 
±³À°½Ã°£ 01-13 Presentation Arena 16:20~16:30 Antegrade Dissection and Re-entry  ±èÁö¹Ú(°í·ÁÀÇ´ë) 
±³À°½Ã°£ 01-13 Presentation Arena 16:30~16:40 Reverse CART(Controlled Antegrade and Retrograde Tracking)  ÇãÁ¤È£(°í½ÅÀÇ´ë) 
±³À°½Ã°£ 01-13 Presentation Arena 16:40~16:50 Retrograde Knuckle Wire Technique  È²º´Èñ(°¡Å縯ÀÇ´ë) 
Åä·Ð 01-13 Presentation Arena 16:50~17:10 Discussion  () 
±³À°½Ã°£ 01-13 Main Arena 17:15~17:23 TAVR(Transcatheter Aortic Valve Replacement): When Transfemoral Access Is Not Feasible  ±Ç¿À¼º(°¡Å縯ÀÇ´ë) 
±³À°½Ã°£ 01-13 Main Arena 17:23~17:31 Pre- and post- TAVR(Transcatheter Aortic Valve Replacement) Balloon Valvuloplasty: When and Whom  ÀÌ»ó·Ï(ÀüºÏÀÇ´ë) 
±³À°½Ã°£ 01-13 Main Arena 17:31~17:39 TAVR(Transcatheter Aortic Valve Replacement) in Patients with Low Ejection Fraction  ÀÌÇÑö(ºÎ»êÀÇ´ë) 
±³À°½Ã°£ 01-13 Main Arena 17:39~17:47 Coronary Obstruction during & after TAVR(Transcatheter Aortic Valve Replacement): Prevention and Management  ±è¿øÀå(Â÷ÀÇ´ë) 
±³À°½Ã°£ 01-13 Main Arena 17:47~17:55 Annular Rupture: Risk Factors and Prevention  ±¹Çüµ·(ÇѾçÀÇ´ë) 
Åä·Ð 01-13 Main Arena 17:55~18:15 Discussion  () 
±âŸ 01-13 Symposium Arena 17:15~17:23 SFR(Stent Failure Research Club) General Meeting  () 
±³À°½Ã°£ 01-13 Symposium Arena 17:23~17:31 DCB(Drug-coated Balloon) Treatment 2022 Publication Updates  Á¶À±°æ(°è¸íÀÇ´ë) 
±³À°½Ã°£ 01-13 Symposium Arena 17:31~17:39 Optimal DCB(Drug-coated Balloon) Treatment, Focus on Technique  ÀÌ»ó¿±(Áß¾ÓÀÇ´ë) 
±³À°½Ã°£ 01-13 Symposium Arena 17:39~17:47 Role of DCB(Drug-coated Balloon) in CTO(Chronic Total Occlusion), Bifurcation, Calcified CAD(Coronary Artery Disease)  À¯»ó¿ë(¿ï»êÀÇ´ë) 
±³À°½Ã°£ 01-13 Symposium Arena 17:47~17:55 DCB(Drug-coated Balloon) Treatment for De Novo CAD(Coronary Artery Disease)  Çã¾Ö¿µ(°­¿øÀÇ´ë) 
Åä·Ð 01-13 Symposium Arena 17:55~18:15 Discussion  () 
±³À°½Ã°£ 01-13 Presentation Arena 17:15~17:25 Which Wires for Individual Lesions  ±è¼öÈ«(ºÎ»êº¸Èƺ´¿ø) 
±³À°½Ã°£ 01-13 Presentation Arena 17:25~17:35 Distal Puncture and Pedal Loop Technique: Master  À̽Âȯ(¿ï»êÀÇ´ë) 
±³À°½Ã°£ 01-13 Presentation Arena 17:35~17:45 Initial Planning for Intervention in PAD(Peripheral Artery Disease) (Multilevel or Bilateral Involvement)  ¹ÚÅñÔ(¼º±Õ°üÀÇ´ë) 
±³À°½Ã°£ 01-13 Presentation Arena 17:45~17:55 When to Go Bypass Surgery or Endovascular Intervention: Initially or After Procedure Failure  ÀÌÁ¾¿µ(¼º±Õ°üÀÇ´ë) 
±³À°½Ã°£ 01-13 Presentation Arena 17:55~18:05 Acute Limb Ischemia: How to Approach  ±ÇÁر³(¿ï»êÀÇ´ë) 
Åä·Ð 01-13 Presentation Arena 18:05~18:15 Discussion  () 
ÆÄ¿ö¸µÅ© ±¤°íµî·Ï
ÀÌ °Ô½Ã¹°À» ÃßõÇÕ´Ï´Ù.
¸Þµð¾÷
" ´ëÇѽÉÇ÷°üÁßÀçÇÐȸ Á¦19ȸ µ¿°è±¹Á¦Çмú´ëȸ(1ÀÏÂ÷) : 2023-01-13""ÀÇ ÀÌ¿ëÈı⳪ Ãßõ´ñ±ÛÀ» ³²°Ü À¯¿ëÇÑ Á¤º¸·Î °øÀ¯ÇսôÙ. ^^
¡å
ÀÌ °Ô½Ã¹°À» ÃßõÇÕ´Ï´Ù.
 
¸ñ·Ï ¼öÁ¤ »èÁ¦
ÀÌÀü±Û »ï¼º¼­¿ïº´¿ø 2023 ÁßÁõ½ÉºÎÀü ½ÉÆ÷Áö¾ö : 2023-01-13
´ÙÀ½±Û (¿Â¶óÀÎ) 2022³â »ó¹Ý±â ÀÇÇй°¸® Àü¹®±³À° 1 : 2023-01-13
¹øÈ£ Á¦¸ñ Ãßõ Á¶È¸ µî·ÏÀÏ
20694 ´ëÀü Á¦8ȸ ³»ºÐºñ ÃÊÀ½ÆÄ ¹× ±â´É°Ë»ç ¿¬¼ö°­Á : 2024-06-29 0 73 2024-05-11
20693 ¼­¿ï (¿Â¶óÀÎ) ´ëÇѼ¼Æ÷º´¸®ÇÐȸ Á¦32Â÷ º´¸®Àǻ縦 À§ÇÑ ¼¼Æ÷º´¸®±³À° 4Â÷ : 2024-06-29 0 40 2024-05-11
20692 ¼­¿ï Á¦24ȸ ´ëÇÑÀ¯Àü¼º´ë»çÁúȯÇÐȸ Á¤±âÇмú´ëȸ : 2024-06-28 0 48 2024-05-11
20691 °æ±â Á¤½Å°Ç°­ÀÇÇаú ÀÓ»ó¿¡¼­ À¯¿ëÇÑ Ä¡·á¹ý : 2024-06-26 0 54 2024-05-11
20690 ¼­¿ï (¿Â¶óÀÎ)2024 ÇѾç´ëÇб³º´¿ø È£Èí±â¾Ë·¹¸£±â ¿¬¼ö°­Á : 2024-06-22 0 44 2024-05-11
20689 ºÎ»ê °í½Å´ëÇб³º¹À½º´¿ø Á¦20ȸ °©»ó¼±¿¬¼öȸ : 2024-06-22 0 44 2024-05-11
20688 ¼­¿ï (¿Â¶óÀÎ) ´ëÇѼ¼Æ÷º´¸®ÇÐȸ Á¦32Â÷ º´¸®Àǻ縦 À§ÇÑ ¼¼Æ÷º´¸®±³À° 3Â÷ : 2024-06-22 0 21 2024-05-11
20687 ¼­¿ï ´ëÇѺÎÁ¤¸ÆÇÐȸ KHRS Annual Scientific Session 2024 (2ÀÏÂ÷) : 2024-06-22 0 18 2024-05-11
20686 ¼­¿ï Á¦50Â÷ ´ëÇѾÏÇÐȸ Çмú´ëȸ 2 : 2024-06-21 0 45 2024-05-11
20685 ¼­¿ï ´ëÇѺÎÁ¤¸ÆÇÐȸ KHRS Annual Scientific Session 2024 (1ÀÏÂ÷) : 2024-06-21 0 22 2024-05-11
20684 ¼­¿ï Á¦50Â÷ ´ëÇѾÏÇÐȸ Çмú´ëȸ 1 : 2024-06-20 0 18 2024-05-11
20683 ¼­¿ï ´ëÇѸ¶ÃëÅëÁõÀÇÇÐȸ (¿Â¶óÀÎ) ¼­¿ï°æÀÎÁöȸ 277Â÷ ¿ù·ÊÁý´ãȸ : 2024-06-18 0 45 2024-05-11
20682 ¼­¿ï 2024 °­µ¿±¸ÀÇ»çȸ Á¦3Â÷ ¿¬¼ö±³À°(¿°Áõ¼º ÀåÁúȯ,ºñ¸¸ ¾à¹° Ä¡·á ) : 2024-06-17 0 31 2024-05-11
20681 ¼­¿ï ´ëÇÑ´ç´¢º´ÇÐȸ Á¦29Â÷ ´ç´¢º´ ¿¬¼ö°­Á : 2024-06-16 0 33 2024-05-11
20680 ¼­¿ï (¿Â¶óÀÎ) ´ëÇѼ¼Æ÷º´¸®ÇÐȸ Á¦32Â÷ º´¸®Àǻ縦 À§ÇÑ ¼¼Æ÷º´¸®±³À° 2Â÷ : 2024-06-15 0 28 2024-05-11
1 | 2 | 3 | 4 | 5 | 6 | 7 | 8 | 9 | 10
 
Ä¿¹Â´ÏƼ
°Ô½ÃÆÇ
°Ç°­Á¤º¸
º´¿ø¾à±¹
Èú¸µ½ºÅ丮
Áúº´Á¤º¸
ÀǾàÇ°Á¤º¸
ÀÇÇм­Àû
ÀÓ´ë¸Å¸Å
¿¬¼ö°­ÁÂ
±³À°Á¤º¸
º´¿øȨÆäÀÌÁö
¸ÞµðÅå
ÇÑÀÇ¿ø
¼ºÇü¿Ü°ú
Ä¡°ú
¾È°ú
¿©¼ºº´¿ø
³»°ú
Á¤Çü¿Ü°ú
ÇǺΰú
¼Ò¾Æ°ú
À̺ñÀÎÈÄ°ú
ºñ´¢ÀÇÇаú
¿ä¾çº´¿ø
ÀçÈ°ÀÇÇаú
µ¿¹°º´¿ø
±âŸº´ÀÇ¿ø
Ãë¾÷°ü·Ã
Áö¿ø¼­¾ç½Ä
¼­·ù¾ç½Ä
¸Þµð¾÷ ¸ð¹ÙÀÏÀ¥
¸Þµð¾÷